NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 2, Pages e2634-e2634
Publisher
Springer Nature
Online
2017-02-23
DOI
10.1038/cddis.2017.44
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The rationale for targeting TGF-β in chronic liver diseases
- (2016) Gianluigi Giannelli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- TGF-β signalling and liver disease
- (2016) Isabel Fabregat et al. FEBS Journal
- Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
- (2015) Erica Villa et al. GUT
- Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
- (2015) Cindy Neuzillet et al. Oncotarget
- Circulating TGF-β1-related biomarkers in patients with hepatocellular carcinoma and their association with HCC staging scores
- (2014) Francesco Dituri et al. CANCER LETTERS
- Transforming Growth Factor- as a Therapeutic Target in Hepatocellular Carcinoma
- (2014) G. Giannelli et al. CANCER RESEARCH
- TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells
- (2014) Thanh Thao Vo Nguyen et al. CANCER SCIENCE
- Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
- (2014) Gianluigi Giannelli et al. GUT
- Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease
- (2013) Adam M Zawada et al. Epigenetics
- A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
- (2013) Jean–Charles Nault et al. GASTROENTEROLOGY
- Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
- (2013) Francesco Dituri et al. PLoS One
- SnoN activates p53 directly to regulate aging and tumorigenesis
- (2012) Deng Pan et al. AGING CELL
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- TGF-� Signaling in Onset and Progression of Hepatocellular Carcinoma
- (2012) Nadja M. Meindl-Beinker et al. DIGESTIVE DISEASES
- Transforming Growth Factor-β/SMAD Target GeneSKILIs Negatively Regulated by the Transcriptional Cofactor Complex SNON-SMAD4
- (2012) Angeles C. Tecalco-Cruz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
- (2011) Massimo Iavarone et al. HEPATOLOGY
- Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study
- (2010) Emilia Fransvea et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Transforming Growth Factor- (TGF- )-Inducible Gene TMEPAI Converts TGF- from a Tumor Suppressor to a Tumor Promoter in Breast Cancer
- (2010) P. K. Singha et al. CANCER RESEARCH
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
- (2008) David Padua et al. CELL
- Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
- (2008) Cédric Coulouarn et al. HEPATOLOGY
- Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
- (2008) Emilia Fransvea et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started